The immune system and cancer: the evolving role of molecular imaging and molecular targeted therapy

被引：0
|
作者：
Giovanni Lucignani
机构：
[1] University of Milan and Unit of Molecular Imaging,Institute of Radiological Sciences
[2] Division of Radiation Therapy,undefined
[3] European Institute of Oncology,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：503 / 505
页数：2
相关论文
共 50 条
  • [21] Molecular targeted therapy for lung cancer
    Onn, A
    Herbst, RS
    LANCET, 2005, 366 (9496): : 1507 - 1508
  • [22] Molecular targeted therapy in advanced cancer
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4833 - 4834
  • [23] Molecular targeted therapy for breast cancer
    Yoshinori Ito
    Breast Cancer, 2007, 14 (2) : 131 - 131
  • [24] Molecular targeted therapy for lung cancer
    Nakaoku, Takashi
    Kohno, Takashi
    CANCER SCIENCE, 2018, 109 : 635 - 635
  • [25] Radiometallated peptides for molecular imaging and targeted therapy
    Correia, Joao D. G.
    Paulo, Antonio
    Raposinho, Paula D.
    Santos, Isabel
    DALTON TRANSACTIONS, 2011, 40 (23) : 6144 - 6167
  • [26] Molecular imaging and therapy of atherosclerosis with targeted nanoparticles
    Wickline, Samuel A.
    Neubauer, Anne M.
    Winter, Patrick M.
    Caruthers, Shelton D.
    Lanza, Gregory M.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2007, 25 (04) : 667 - 680
  • [27] Molecular imaging in cancer therapy
    Weber, W. A.
    ONKOLOGE, 2011, 17 (05): : 395 - +
  • [28] Molecular imaging in cancer therapy
    Weber, W. A.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2010, 53 (08) : 810 - 817
  • [29] The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy
    Timothy H. Witney
    Philip J. Blower
    Cancer Imaging, 21
  • [30] The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy
    Witney, Timothy H.
    Blower, Philip J.
    CANCER IMAGING, 2021, 21 (01)
12345